Has Marcel Rivard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,852 in general payments to Marcel Rivard, MD across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marcel Rivard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marcel Rivard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marcel Rivard, MD

Vascular & Interventional Radiology · Minneapolis, MNNPI 1457799181

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,714 of the $16,852 with a category attached, or 69.5%. 18 manufacturers reported payments, led by Abbott at 26.7% of the total.

$16,852in general payments, 2019–2025

Across 132 payments — averaging $127.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$5K
Penumbra, Inc.$4K
Bard Peripheral Vascular, Inc.$2K
Galil Medical Inc.$1K
Shockwave Medical, Inc$1K
W. L. Gore & Associates, Inc.$1K
plus $3K from 12 others

What the payments were for

Consulting fees$1,3508%
Travel & lodging$3,78822%
Food & beverage$11,71470%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	33	$4,507
Penumbra, Inc.	19	$3,685
Bard Peripheral Vascular, Inc.	17	$1,759
Galil Medical Inc.	2	$1,357
Shockwave Medical, Inc	12	$1,242
W. L. Gore & Associates, Inc.	12	$1,039
Medtronic(2 entities)	11	$930
Boston Scientific	9	$742
Philips North America LLC	4	$327
Terumo Medical Corporation	2	$258
Inari Medical, Inc.	2	$201
Sirtex Medical Inc	1	$182
Stryker	1	$150
Surmodics, Inc.	2	$141
Venturemed Group, Inc.	1	$135
Biocompatibles, Inc.	1	$126
Northern X-ray Company	2	$48
Trisalus Life Sciences, Inc.	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Indigo System$2,837
SUPERA$1,933
ICEFX$1,350
Omnilink Elite vascular stent system$1,146
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$984
Abre$391
Ruby$359
COVERA$285
EXCLUDER Conformable AAA Endoprosthesis with Active Control$277
RUBY Coil$254
IN.PACT Admiral$254
GORE VIABAHN Endoprosthesis with Heparin$198
SIR-Spheres Microspheres$182
JETi Peripheral Catheter$169
GENERAL - THERAPIES$169
Supera peripheral stent system$161
ESPRIT$157
DECATHLON$153
General - Interventional Oncology$152
LIMFLOW SYSTEM$150

How this compares

$16,852 in reported general payments places this provider in the 80th percentile of 78 vascular & interventional radiology providers in Minnesota.

See all vascular & interventional radiology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$63,800

Medicare patients

710

Services billed

1,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Minneapolis

Michael RosenbergMinneapolis$134K
Reza TalaieMinneapolis$64K
Bjorn EngstromMinneapolis$55K
Sameer GadaniMinneapolis$33K
Donna DsouzaMinneapolis$29K
Nassir RostambeigiMinneapolis$16K
Derrick ChuMinneapolis$15K
Prashant ShresthaMinneapolis$12K
Siobhan FlanaganMinneapolis$12K
Asad IrfanullahMinneapolis$8K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →